no statement of use filed
on 28 Aug 2023
Last Applicant/ Owned by
66 Hudson Boulevard East
New York
NY
100012192
Serial Number
88785466 filed on 05th Feb 2020
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations forRead More
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
No 88785466
No Service/Collective Mark
No T429563
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 28th Aug 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| 28th Aug 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 28th Mar 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 28th Mar 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 28th Mar 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 28th Mar 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 28th Mar 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 16th Dec 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 15th Dec 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 15th Dec 2022 | SOU EXTENSION 5 GRANTED |
